Fortitude Family Office »

Lyra Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2025-09-30 $626 96 6.53

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard S&p 500 Etf Etf (VOO)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Vanguard Mid-cap Etf Etf (VO)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares U.s. Technology Etf Etf (IYW)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Fortitude Family Office

Top funds holding Lyra Therapeutics

Perceptive Advisors
Sabby Management
Vanguard Group
Ikarian Capital
Citadel Advisors
Geode Capital Management
UBS Group
Morgan Stanley
BlackRock
Royal Bank of Canada
Tower Research Capital
FMR
Signature Resources Capital Management
EverSource Wealth Advisors
Jones Financial Companies, L.L

View all funds holding Lyra Therapeutics